Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Dec 31, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 84.4M | 78.5M | 88.3M | 79.1M | 71.0M |
| Operating Revenue | 84.4M | 78.5M | 88.3M | 79.1M | 71.0M |
| Cost Of Revenue | -22.1M | 52.9M | 52.2M | 48.4M | 49.7M |
| Gross Profit | 106.5M | 25.7M | 36.1M | 30.7M | 21.3M |
| Selling General And Administration | 8.1M | 3.1M | 3.4M | 6.2M | 3.2M |
| General And Administrative Expense | 7.7M | 2.7M | 3.0M | 5.9M | 2.9M |
| Other Operating Expenses | 1.1M | 2.2M | 1.8M | 1.6M | 2.2M |
| Operating Expense | 9.2M | 5.3M | 5.2M | 7.9M | 5.4M |
| Operating Income | 97.3M | 20.3M | 30.9M | 22.8M | 15.9M |
| EBIT | 104.4M | 44.4M | 25.5M | 16.1M | 32.9M |
| Interest Expense | 6.5M | 6.3M | 6.9M | 6.9M | 7.1M |
| Interest Expense Non Operating | 6.5M | 6.3M | 6.9M | 6.9M | 7.1M |
| Net Interest Income | -6.6M | -6.4M | -7.0M | -7.0M | -7.2M |
| Other Income Expense | 7.2M | 24.2M | -5.2M | -6.6M | 17.1M |
| Other Non Operating Income Expenses | 2.3M | 2.7M | 3.9M | 3.1M | 2.6M |
| Gain On Sale Of Security | 4.9M | 21.6M | -9.1M | -9.7M | 14.5M |
| Pretax Income | 97.9M | 38.1M | 18.7M | 9.2M | 25.8M |
| Tax Provision | 21.0M | 10.0M | 6.4M | 4.8M | 7.8M |
| Tax Effect Of Unusual Items | 1.0M | 5.6M | -3.1M | -1.5M | 4.4M |
| Net Income From Continuing And Discontinued Operation | 76.9M | 28.2M | 12.3M | 4.4M | 18.0M |
| Net Income From Continuing Operation Net Minority Interest | 76.9M | 28.2M | 12.3M | 4.4M | 18.0M |
| Net Income Including Noncontrolling Interests | 76.9M | 28.2M | 12.3M | 4.4M | 18.0M |
| Net Income Common Stockholders | 76.9M | 28.2M | 12.3M | 4.4M | 18.0M |
| Net Income | 76.9M | 28.2M | 12.3M | 4.4M | 18.0M |
| EBITDA | 104.4M | 97.3M | 77.7M | 64.5M | 82.6M |
| Normalized EBITDA | 99.5M | 75.7M | 86.8M | 74.2M | 68.1M |
| Reconciled Depreciation | -22.1M | 52.9M | 52.2M | 48.4M | 49.7M |
| Basic EPS | -- | 0.18 | 0.08 | -- | 0.12 |
| Diluted EPS | -- | 0.18 | 0.08 | -- | 0.12 |
| Basic Average Shares | -- | 153.8M | 153.8M | -- | 144.9M |
| Diluted Average Shares | -- | 154.4M | 154.4M | -- | 145.6M |
| Total Unusual Items | 4.9M | 21.6M | -9.1M | -9.7M | 14.5M |
| Total Unusual Items Excluding Goodwill | 4.9M | 21.6M | -9.1M | -9.7M | 14.5M |
| Tax Rate For Calcs | 0.21 | 0.26 | 0.34 | 0.15 | 0.30 |
| Normalized Income | 73.1M | 12.2M | 18.3M | 12.7M | 7.9M |
| Diluted NI Availto Com Stockholders | 76.9M | 28.2M | 12.3M | 4.4M | 18.0M |
| Net Income Continuous Operations | 76.9M | 28.2M | 12.3M | 4.4M | 18.0M |
| Net Non Operating Interest Income Expense | -6.6M | -6.4M | -7.0M | -7.0M | -7.2M |
| Other Gand A | 3.3M | 1.9M | 2.2M | 2.9M | 1.7M |
| Reconciled Cost Of Revenue | -22.1M | 52.9M | 52.2M | 48.4M | 49.7M |
| Salaries And Wages | 4.4M | 834,000 | 789,000 | 3.0M | 1.1M |
| Selling And Marketing Expense | 415,000 | 370,000 | 445,000 | 356,000 | 279,000 |
| Total Expenses | -12.9M | 58.2M | 57.4M | 56.3M | 55.1M |
| Total Other Finance Cost | 146,000 | 169,000 | 100,000 | 100,000 | 100,000 |
| Line Item | Q4 2025Dec 31, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 580,000 | 306,000 | 0.00 | 147,000 | 0.00 |
| Cash Cash Equivalents And Short Term Investments | 580,000 | 12.9M | 5.2M | 147,000 | 0.00 |
| Cash Financial | 580,000 | 306,000 | 0.00 | 147,000 | 0.00 |
| Other Short Term Investments | -- | 12.6M | 5.2M | 10.6M | -- |
| Accounts Receivable | 55.6M | 49.3M | 55.4M | 52.5M | 44.2M |
| Receivables | 55.6M | 49.3M | 55.4M | 52.5M | 44.2M |
| Prepaid Assets | 721,000 | 623,000 | 821,000 | 786,000 | 371,000 |
| Current Assets | 61.5M | 62.9M | 61.5M | 64.0M | 58.6M |
| Gross PPE | 2.8B | 2.8B | 2.7B | 2.7B | 2.4B |
| Accumulated Depreciation | -682.4M | -980.9M | -928.0M | -547.3M | -827.5M |
| Net PPE | 2.2B | 1.8B | 1.8B | 2.2B | 1.6B |
| Total Non Current Assets | 2.2B | 1.8B | 1.8B | 2.2B | 1.6B |
| Total Assets | 2.2B | 1.8B | 1.9B | 2.2B | 1.6B |
| Payables And Accrued Expenses | 3.6M | 10.0M | 6.8M | 6.3M | 30.9M |
| Other Current Liabilities | 1.8M | 2.3M | 8.0M | 6.0M | 215,000 |
| Current Liabilities | 5.5M | 12.2M | 14.8M | 12.3M | 31.1M |
| Long Term Debt | 570.8M | 525.5M | 530.2M | 540.4M | 419.5M |
| Long Term Debt And Capital Lease Obligation | 570.8M | 525.5M | 530.2M | 540.4M | 419.5M |
| Total Non Current Liabilities Net Minority Interest | 695.8M | 566.4M | 564.3M | 629.0M | 441.7M |
| Total Liabilities Net Minority Interest | 701.2M | 578.6M | 579.1M | 641.3M | 472.8M |
| Common Stock | 1.7B | 1.7B | 1.7B | 1.7B | 1.5B |
| Capital Stock | 1.7B | 1.7B | 1.7B | 1.7B | 1.5B |
| Additional Paid In Capital | 71.2M | 60.4M | 58.8M | 63.8M | 58.6M |
| Retained Earnings | -295.3M | -544.5M | -520.4M | -216.4M | -435.8M |
| Common Stock Equity | 1.5B | 1.3B | 1.3B | 1.6B | 1.2B |
| Stockholders Equity | 1.5B | 1.3B | 1.3B | 1.6B | 1.2B |
| Total Equity Gross Minority Interest | 1.5B | 1.3B | 1.3B | 1.6B | 1.2B |
| Total Capitalization | 2.1B | 1.8B | 1.8B | 2.1B | 1.6B |
| Net Tangible Assets | 1.5B | 1.3B | 1.3B | 1.6B | 1.2B |
| Tangible Book Value | 1.5B | 1.3B | 1.3B | 1.6B | 1.2B |
| Working Capital | 56.0M | 50.6M | 46.7M | 51.8M | 27.5M |
| Invested Capital | 2.1B | 1.8B | 1.8B | 2.1B | 1.6B |
| Total Debt | 570.8M | 525.5M | 530.2M | 540.4M | 419.5M |
| Net Debt | 570.2M | 525.2M | 530.2M | 540.2M | 419.5M |
| Share Issued | 154.0M | 153.8M | 153.8M | 153.5M | 144.9M |
| Ordinary Shares Number | 154.0M | 153.8M | 153.8M | 153.5M | 144.9M |
| Derivative Product Liabilities | 0.00 | 2.5M | 5.7M | 4.9M | 3.0M |
| Financial Assets | 821,000 | 711,000 | 546,000 | 2.3M | 4.4M |
| Hedging Assets Current | 4.5M | -- | -- | 10.6M | 14.0M |
| Long Term Provisions | 5.4M | 5.6M | 5.7M | 5.4M | 5.1M |
| Non Current Deferred Assets | -- | -- | -- | 0.00 | 0.00 |
| Non Current Deferred Liabilities | 119.6M | 32.8M | 22.8M | 78.3M | 14.2M |
| Non Current Deferred Taxes Assets | -- | -- | -- | 0.00 | 0.00 |
| Non Current Deferred Taxes Liabilities | 119.6M | 32.8M | 22.8M | 78.3M | 14.2M |
| Treasury Shares Number | -- | -- | -- | -- | -- |
| Line Item | Q4 2025Dec 31, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | 69.1M | 80.7M | 80.7M | 64.9M | 71.3M |
| Cash Flow From Continuing Operating Activities | 69.1M | 80.7M | 80.7M | 64.9M | 71.3M |
| Depreciation Amortization Depletion | -22.1M | 52.9M | 52.2M | 48.4M | 49.7M |
| Stock Based Compensation | 4.4M | 834,000 | 789,000 | 3.0M | 1.1M |
| Deferred Tax | 21.0M | 10.0M | 6.4M | 4.8M | 7.8M |
| Deferred Income Tax | 21.0M | 10.0M | 6.4M | 4.8M | 7.8M |
| Change In Working Capital | -11.4M | 5.1M | -1.0M | -8.9M | 4.3M |
| Other Non Cash Items | 198,000 | 219,000 | 145,000 | 145,000 | 140,000 |
| Capital Expenditure | -11.1M | -27.6M | -18.4M | -312.5M | -7.8M |
| Purchase Of PPE | -11.1M | -27.6M | -18.4M | -312.5M | -7.8M |
| Net PPE Purchase And Sale | -11.1M | -27.6M | -18.4M | -312.5M | -7.8M |
| Investing Cash Flow | -83.3M | -27.2M | -19.6M | -336.8M | -1.1M |
| Cash Flow From Continuing Investing Activities | -83.3M | -27.2M | -19.6M | -336.8M | -1.1M |
| Repayment Of Debt | -- | -- | -10.3M | -- | -- |
| Net Issuance Payments Of Debt | 66.0M | -3.2M | -10.3M | 120.8M | -22.8M |
| Common Stock Dividend Paid | -52.4M | -52.3M | -50.7M | -50.6M | -47.8M |
| Financing Cash Flow | 14.4M | -53.2M | -61.3M | 272.1M | -70.1M |
| Cash Flow From Continuing Financing Activities | 14.4M | -53.2M | -61.3M | 272.1M | -70.1M |
| Changes In Cash | 149,000 | 306,000 | -147,000 | 147,000 | -- |
| Beginning Cash Position | 431,000 | 0.00 | 147,000 | 0.00 | 0.00 |
| End Cash Position | 580,000 | 306,000 | 0.00 | 147,000 | 0.00 |
| Free Cash Flow | 58.0M | 53.1M | 62.4M | -247.6M | 63.5M |
| Cash Dividends Paid | -52.4M | -52.3M | -50.7M | -50.6M | -47.8M |
| Long Term Debt Payments | -- | -- | -10.3M | -- | -- |
| Net Income From Continuing Operations | 76.9M | 28.2M | 12.3M | 4.4M | 18.0M |
| Net Long Term Debt Issuance | 66.0M | -3.2M | -10.3M | 120.8M | -22.8M |
| Net Other Financing Charges | -275,000 | 2.2M | -256,000 | -8.8M | -13,000 |
| Net Other Investing Changes | -72.2M | 401,000 | -1.2M | -24.3M | 6.6M |
| Proceeds From Stock Option Exercised | 987,000 | 0.00 | 0.00 | 3.8M | 550,000 |
| Unrealized Gain Loss On Investment Securities | 214,000 | -16.4M | 9.9M | 13.2M | -9.8M |